Results 111 to 120 of about 87,718 (183)

NOVEL CORONAVIRUS (2019-nCoV): DISEASE BRIEFINGS

open access: yesAsian Journal of Pharmaceutical and Clinical Research, 2020
Coronavirus (CoV) (2019‐nCoV) is a large, enveloped, positive-sense, single-stranded RNA virus. The abnormal outbreak of 2019‐nCoV in Wuhan warns of the risk of CoV (2019‐nCoV) to public health which causes viral pneumonia outbreak. In our review, we will discuss the biology of CoVs and the potential risk of the novel CoV (2019‐nCoV) and guide us to ...
KANAAN AL-TAMEEMI, RAIAAN KABAKLI
openaire   +2 more sources

Strategies of renal replacement therapy in the outbreak of the novel coronavirus

open access: yesLinchuang shenzangbing zazhi, 2020
The novel coronavirus(2019-nCoV) is a newly identified virus transmitted by respiratory droplets. The virus spreads aggressively and causes a cluster of cases with severe and lethal pneumonia.
LIANG Wei, SHI Ming, WANG Hui-ming
doaj  

When does a major outbreak become a Public Health Emergency of International Concern? [PDF]

open access: yes, 2020
The process of determining whether a Public Health Emergencies of International Concern (PHEIC) exists and should be declared has drawn increasing criticism over the past few years with allegations that it is more political than technical.
Durrheim, David N.   +2 more
core   +1 more source

2019-nCoV: Verdachtsabklärung und Maßnahmen

open access: yes, 2020
Hinweise für Ärzte und Ärztinnen zum Erkennen einer möglichen Infektion mit dem neuartigen Erreger n-CoV und zu den ersten notwendigen Maßnahmen.
openaire   +7 more sources

Machine intelligence design of 2019-nCoV drugs

open access: yes, 2020
AbstractWuhan coronavirus, called 2019-nCoV, is a newly emerged virus that infected more than 9692 people and leads to more than 213 fatalities by January 30, 2020. Currently, there is no effective treatment for this epidemic. However, the viral protease of a coronavirus is well-known to be essential for its replication and thus is an effective drug ...
Gao, Kaifu   +3 more
openaire   +3 more sources

Novel, Inexpensive Portable Respiratory Protection Unit (PRPU) for Healthcare Workers [PDF]

open access: yes, 2020
Introduction: Given concern for increased aerosolization during intubation of patients with severe acute respiratory syndrome coronavirus, we sought to create a portable, inexpensive, and easily constructed device to help protect healthcare workers ...
Beckett, Adam, Sampson, Christopher S.
core  

Coronavirus 2019-nCoV (short message)

open access: yesMedAlliance, 2019
В статье представлены данные исследований коронавируса 2019-nCoV. Впервые заболевание было зарегистрировано в декабре 2019 года в Китае. Новый коронавирус, вначале названный Ухань, а затем обозначенный как 2019-nCoV, 7 января 2020 г. был официально объявлен китайскими властями возбудителем болезни.
openaire   +2 more sources

On Identifying and Mitigating Bias in the Estimation of the COVID-19 Case Fatality Rate

open access: yes, 2020
The relative case fatality rates (CFRs) between groups and countries are key measures of relative risk that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. In the middle of an active outbreak when
Angelopoulos, Anastasios Nikolas   +3 more
core  

Comparison of Abbott real time SARS-COV-2 assay and Liferiver Novel Coronavirus Real Time Multiplex kit for the RT-PCR based detection of SARS-COV-2 from nasopharyngeal swabs

open access: yesActa Clinica Croatica
The objective of this study was to compare performance of two authorized tests, the Abbott Real Time SARS–CoV-2 (ACOV) assay (Abbott Molecular Inc., North Chicago, IL, USA) and Liferiver Novel Coronavirus Real Time Multiplex RT-PCR (Liferiver 2019-nCoV)
Jelena Stojčević-Maletić   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy